Immunic focusing on business development during Q4 : vimarsa

Immunic Inc President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive London after the Munich-based biotech company released a third-quarter update.Dr Vitt starts by describing the...

Related Keywords

Munich , Bayern , Germany , United States , London , City Of , United Kingdom , Thomas Warner , Daniel Vitt , Us Patent Office , Immunic Inc , Sinc President , Proactive London , Progressive Multiple ,